Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 10 SEPTEMBER 2012

Client Relationship Model II - Cost Disclosure, Performance Reporting And Client Statements Update

Fasken
Explore more from Fasken

On June 14, 2012, the Canadian Securities Administrators (CSA) published for comment a second version of amendments to National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations (NI 31-103) with respect to the second phase of the Client Relationship Model initiative (CRM II).

CanadaWealth Management
Pierre-Yves ChâTillon
Pierre-Yves ChâTillon
Garth J. Foster
Garth J. Foster
Author LinkedIn connections

On June 14, 2012, the Canadian Securities Administrators (CSA) published for comment a second version of amendments to National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations (NI 31-103) with respect to the second phase of the Client Relationship Model initiative (CRM II).

CRM II is designed to give investors key information to better assist them in understanding the charges they pay in respect of their investments, the compensation received by their dealer and/or adviser and the performance of their account. The first phase of the Client Relationship Model was part of NI 31-103 when it became effective on September 28, 2009 and included the need for a relationship disclosure document when a client opened an account.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

2004 Ontario Budget: Limited Liability Legislation for Income Funds

The 2004 Ontario budget, announced today, confirms that the Ontario government will propose technical legislation to clarify that investors in publicly traded trusts will not be liable for the activities of the trust. This is consistent with the announcement included as part of the <I>2003 Ontario Economic Outlook and Fiscal Review</I> released on December 17, 2003 by Finance Minister Greg Sorbara
CanadaWealth Management
Goodmans LLP
Goodmans LLP
Article

Registered Disability Savings Plans: What You Should Know

Registered Disability Savings Plans offer eligible Canadians a powerful tool to build tax-deferred savings for life after 60, complete with government matching grants up to $70,000 and bonds up to $20,000. Despite these significant benefits, only one-third of eligible Canadians have opened an RDSP. Understanding how these plans work, including contribution limits, withdrawal rules, and eligibility requirements, can help individuals with disabilities secure their financial future.
CanadaWealth Management
Gluckstein Lawyers
Gluckstein Lawyers
Article

Canadian-Australian Pension Funds Investment Initiative: Cross-investment To Strengthen A Natural Partnership

The Canadian-Australian Pension Funds Investment Initiative establishes a groundbreaking framework for cross-border pension fund investment between two of the world's most sophisticated pension markets. This analysis examines the policy barriers, regulatory considerations, and opportunities for deploying long-term infrastructure capital across both jurisdictions, including asset recycling strategies and sectoral dimensions.
CanadaWealth Management
Dentons Canada LLP
Dentons Canada LLP
Article

More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules

A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
Article

Canada’s Counter-Tariffs On US Goods: A Primer On What Canadian Businesses Need To Know

Effective September 8, 2026, Canada implemented retaliatory tariffs on certain U.S. goods in response to the initial 50% tariffs imposed by the US under Section 338 of the Tariff Act of 1930. To operationalize these measures, the Canada Border Services Agency (CBSA) issued Customs Notice 26-23, establishing binding administrative rules on how the surtax will be applied, calculated, and collected.
CanadaInternational Law
Fasken
Fasken
Article

Life Sciences-Health Canada Takes Action Against Unauthorized Peptide Sales

On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
Article

Buying Quebec, Buying Canadian: What The New Orders In Council 1358-2026 And 1359-2026 Mean For Procurement

Under Order in Council 1358-2026, the Québec government authorizes, from September 7, 2026 to January 31, 2027, the Centre d'acquisitions gouvernementales (the “CAG”) to depart from the general principle that public calls for tenders must be open and without discrimination to foreign suppliers from jurisdictions bound by an intergovernmental agreement with Québec.
CanadaGovernment, Public Sector
Fasken
Fasken
Article

Counter-Tariffs In Force, U.S. Import Bans Announced, A Cabinet Planning Forum, An Investment Summit, EU Diplomatic Overtures And A House Returning

With Labour Day now behind us, Parliament Hill is gearing up for its September 21 return. Canada’s counter-tariffs on nearly $28 billion in American goods are now in force, and the United States has already escalated in response: President Trump has signed measures to ban certain Canadian alcohol, dairy-related products, molasses, non-alcoholic beer, motorcycles and mopeds from entering the U.S. market as of September 29, while modifying the list of Canadian goods subject to 50% tariffs effective September 15 and directing action to remove Canadian-origin products from U.S. government procurement schedules.
CanadaInternational Law
Fasken
Fasken